Description

Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus.

 

It is not known if Mounjaro can be used in people who have had pancreatitis. Mounjaro is not for use in people with type 1 diabetes. It is not known if Mounjaro is safe and effective for use in children under 18 years of age.

 

Image of a down arrow reading up to 90% of people taking Mounjaro reached an a1c under 7%

 

*In studies with or without diabetes medications, 75% to 90% of people taking Mounjaro reached an A1C of less than 7%, with an average starting A1C of 7.9% to 8.6% across the 5-mg, 10-mg, and 15-mg doses.

 

†Study results were measured at 40 and 52 weeks.

 

Select Safety Information

 

Warning: Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Mounjaro and medicines that work like Mounjaro caused thyroid tumors, including thyroid cancer. It is not known if Mounjaro will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not take Mounjaro if you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

 

 

 

Mounjaro is not a weight loss drug.

 

‡Individual results may vary. In studies with or without other diabetes medications, weight loss in adults ranged from 12 lb (5 mg) to 25 lb (15 mg).

 

Select Safety Information

 

Do not use Mounjaro if you or any of your family have ever had a type of thyroid cancer called MTC or if you have an endocrine system condition called MEN 2, or if you have had a serious allergic reaction to tirzepatide or any of the ingredients in Mounjaro.

 

CRM Envelope Icon

 

Get Mounjaro info & lifestyle tips for your real life delivered right to your inbox.

 

Helpful type 2 diabetes information, tasty recipes, and more.

 

SIGN ME UP

 

 

 

Man smiling into camera

 

 

Getting the care you need can be quick and accessible

 

Explore speed, convenience, and access to focused care with independent telehealth or in-person providers through LillyDirect.

 

In-person care

 

Telehealth

 

 

LillyDirect® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

PP-LX-US-0052 07/2024 ©Lilly USA, LLC 2024. All rights reserved.

 

 

Mounjaro Savings

 

We want to help. Learn more about our Savings Program.

 

LEARN MORE

 

By enrolling in and using the Mounjaro Savings Card Program (“Program”) and using the Mounjaro Savings Card (“Card”), you attest that you meet the eligibility criteria, and you agree to comply with the terms and conditions described below:

 

Card Eligibility:

 

You have been prescribed Mounjaro for an approved use consistent with FDA approved product labeling;

You are enrolled in a commercial drug insurance plan;

You are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state prescription drug assista

For patients with commercial drug insurance coverage for Mounjaro: You must have commercial drug insurance that covers Mounjaro®(tirzepatide) and a prescription for an approved use consistent with FDA-approve.

 

For patients with commercial drug insurance who do not have coverage for Mounjaro: You must have commercial drug insurance that does not cover Mounjaro and a prescription for an approved use consistent with FDA-approved product labeling to obtain saving